Global Liver Cancer Treatment Market Size, Share, Future Prospects and Forecast 2018-2023
Liver cancer treatment market is expected to grow at a significant rate during the forecast period 2018-2023. Liver cancer, also referred to as hepatic cancer is a disease that destructs normal cells in the liver and is caused due to hepatitis C and hepatitis B or alcohol consumption. Malignant or cancerous cells that develop in the normal cells of the liver are called hepatocellular carcinoma and the one that arises in the ducts of the liver is called cholangiocarcinoma. The increasing prevalence of liver cancer across the globe and the approval of multiple liver cancer drugs are estimated to be the major factors that are driving the growth of the market. In addition, supporting government initiatives, drug development with regards to cancer and increasing health expenditure is also estimated to be the major factors that are driving the growth of the market.

Request a free sample of our report on Liver Cancer Treatment Market: https://www.omrglobal.com/request-sample/liver-cancer-treatment-market

Over the past few years, the increased prevalence of liver cancer has been witnessed. According to the American Cancer Society, about 42,220 new cases, 30,610 in men and 11,610 in women were diagnosed in 2018 in the US. It was estimated that about 30,200 people, nearly 20,540 men, and 9,660 women will die due to liver cancer in 2018. Since 1980, liver cancer incidence has more than tripled, however, the rates in young adults have begun to decline. The prevalence of liver cancer is seen more often in men than in women. Due to the increasing prevalence of liver cancer, the demand for treatment of liver cancer will increases. As a result, the global liver cancer treatment market is expected to witness growth in the near future.

A full report of Liver Cancer Treatment Market Is available at https://www.omrglobal.com/industry-reports/liver-cancer-treatment-market

Global Liver Cancer Treatment Market Segmentation

By Treatment

Liver Cancer Surgery

Tumor Ablation

Embolization Therapy

Radiation Therapy

Targeted Therapy

Immunotherapy

chemotherapy

By End-User

Hospitals and Clinics

Research Centre

Competitive Landscape

Key Strategy Analysis

Key Company Analysis

Regional Analysis

North America

United States

Canada

Europe

United Kingdom

France

Germany

Italy

Spain

Rest of Europe

Asia-Pacific

China

Japan

India

Rest of Asia-Pacific

Rest of the World

Company Profiles

4SC AG

Alnylam Pharmaceuticals, Inc.

ArQule, Inc.

Aveo Pharmaceuticals, Inc.

Bayer AG

Becton and Dickinson, Co.

Bristol-Myers Squibb, Co.

Celsion Corp.

Dicerna Pharmaceuticals, Inc.

Eli Lilly and Co.

For more customized data, request for report customization @ https://www.omrglobal.com/report-customization/liver-cancer-treatment-market

About Us:

Orion Market Research (OMR) is a market research and consulting company known for its crisp and concise reports. The company is equipped with an experienced team of analysts and consultants. OMR offers quality syndicated research reports, customized research reports, consulting, and other research-based services.

For More Information, Visit https://www.omrglobal.com/

Media Contact:

Company Name: Orion Market Research

Contact Person: Mr. Anurag Tiwari

Email: [email protected]

Contact no: +91 780-304-0404